Navigation Links
Exagen Launches New Diagnostic Assays for Bowel Disease at Digestive Disease Week Conference
Date:5/28/2009

Company signs partnership agreement with Clinical Reference Laboratory

ALBUQUERQUE, N.M., May 28 /PRNewswire/ -- Exagen Diagnostics, Inc. today announced the availability of two new genomic blood tests to assist physicians with diagnosing Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD). Exagen will present the tests at Digestive Disease Week 2009 in Chicago, May 30 - June 4, booth #2429.

The eXaIBStest identifies patients with IBS, while the eXaIBD test identifies patients with IBD. Compared with other available laboratory tests, Exagen's assays produce significantly more accurate test results, providing physicians with more reliable data to aid in diagnosing their patients. The tests were invented using Coperna(TM), Exagen's proprietary genomic data mining software.

"Until now, physicians have relied on a wide range of tests and procedures to aid in the diagnosis of IBS and IBD, including blood tests with limited diagnostic performance," said Exagen President and CEO John Alsobrook, Ph.D. "Approximately 30 million people in the United States suffer from these diseases. Exagen's tests offer physicians several distinct diagnostic advantages, such as increased sensitivity, and we are pleased to make them readily available."

Exagen's tests are RNA-based, and require a single tube of peripheral blood. To support the front-end specimen handling and logistics, Exagen has signed a partnership agreement with Lenexa, Kansas-based Clinical Reference Laboratory (CRL), one of the nation's largest privately held clinical laboratories. This partnership enables Exagen to significantly expand its testing capacity.

"Exagen Diagnostics has developed an extremely promising series of diagnostic assays for gastrointestinal diseases," said Heather Newkirk, Ph.D., CLSp (MB), Executive Director of Molecular Diagnostics at CRL. "We welcome the opportunity to partner with them in bringing these important tests to the physician community."

About Exagen Diagnostics, Inc.

Exagen Diagnostics is a CLIA-registered molecular diagnostics laboratory with a growing menu of proprietary, internally developed genomic tests. For more information, visit www.exagen.com.

About Clinical Reference Laboratory, Inc (CRL Global Services)

Established in 1979, CRL Global Services is a privately held reference laboratory in Lenexa, Kansas offering leading-edge testing services in the areas of Clinical Trials, Molecular Diagnostics, Insurance, and Toxicology. CRL is one of the largest single-site laboratories in the country and analyzes over 80 million tests annually. Additional information is available at www.crlcorp.com.


'/>"/>
SOURCE Exagen Diagnostics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Exagen Diagnostics Names John Alsobrook, Ph.D., Vice President and Chief Operating Officer
2. Quick Medical Launches Medical Equipment Lease Program
3. Snoring Isn't Sexy Launches Public Awareness Campaign
4. Gyminee Raises 525K and Relaunches as DailyBurn
5. Trusted Translations Launches "Translation for St. Jude" Initiative at St. Jude Gala in New York
6. Mayo Clinic Launches Medical Science Blog
7. Transplant Expo Launches in Boston to Educate About Miracle of Transplantation and Address Organ Donor Shortage
8. National Safety Council Launches June National Safety Month With Free Training
9. PHSI Launches New Websites to Promote Sustainable Eco-Friendly Bottle-less Drinking Water Technology
10. Four Rivers Software System Launches TMS OnSite Professional
11. Health and Wellness Partners, Inc., A Wholly Owned Subsidiary of Zealous Inc., Launches Organix+
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... ... January 21, 2017 , ... ... Family Dermatology has recently joined their multi-specialty medical group. The dermatology practice ... cosmetic services. , “We’re excited to add this excellent dermatology practice to our ...
(Date:1/20/2017)... ... ... A new partnership between Goodwill® and Roadie, Inc. aims to make it easier ... couches to dressers and bicycles. Roadie — the national on-the-way delivery network — will ... through February 28th. , “January is an exciting time when resolutions are made ...
(Date:1/20/2017)... ... January 20, 2017 , ... Lice Troopers, the lice removal company based ... school-aged children since the holiday season. , “It happens every year around this ... hugs and taking photos, which is the head-to-head gateway that lice need to spread.” ...
(Date:1/20/2017)... ... 20, 2017 , ... Vitamin Well has launched two new ... have been produced in collaboration with Zlatan Ibrahimovic and have been developed to ... a successful launch in Sweden last year, the next generation sports drinks VW+001 ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... ... vPEP ® Oscillating Positive Expiratory Pressure (OPEP) device, was featured in a study ... Doug Pursley, MEd, RRT-ACCS, FAARC, “Analysis of Three Oscillating Positive Expiratory Pressure ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... -- Report Details What can be expected ... to grow at the fastest rates? This visiongain report ... opportunities and prospects. Our 190-page report provides 124 ... in the industry and the future market prospects. Our ... all the major categories of the ophthalmic devices market. ...
(Date:1/19/2017)... 19, 2017 This report on the opioid ... scenario of the global market. Large number of chronic ... chronic constipation is a major side effect of consumption ... novel targeted therapy has been prescribed to treat opioid ... targeted medicines, and growing awareness about the therapy are ...
(Date:1/19/2017)... 2017 Accuray Incorporated (Nasdaq: ARAY ... continue to set the bar for excellence in customer ... user satisfaction rating among radiation treatment delivery systems in ... Market Intelligence Briefing™. The most recent ratings trend also ... industry peers for 11 of the past 12 quarters. ...
Breaking Medicine Technology: